F5 (NASDAQ:FFIV – Get Rating) posted its earnings results on Tuesday. The network technology company reported $2.47 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.33 by $0.14, RTT News reports. F5 had a net margin of 11.95% and a return on equity of 17.67%. The business had revenue of $700.38 million for the quarter, compared to analysts’ expectations of $700.59 million. During the same period in the prior year, the company posted $2.89 EPS. The business’s revenue for the quarter was up 1.9% compared to the same quarter last year.
F5 Stock Down 0.9 %
Shares of F5 stock opened at $146.47 on Wednesday. The firm has a market cap of $8.84 billion, a PE ratio of 27.69, a price-to-earnings-growth ratio of 1.91 and a beta of 1.09. F5 has a 12-month low of $133.68 and a 12-month high of $225.26. The company’s fifty day simple moving average is $147.28 and its two-hundred day simple moving average is $151.35.
Insiders Place Their Bets
In other F5 news, EVP Ana Maria White sold 170 shares of the firm’s stock in a transaction on Monday, November 14th. The shares were sold at an average price of $149.95, for a total value of $25,491.50. Following the sale, the executive vice president now owns 36,250 shares of the company’s stock, valued at approximately $5,435,687.50. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. In other news, EVP Ana Maria White sold 170 shares of F5 stock in a transaction dated Monday, November 14th. The shares were sold at an average price of $149.95, for a total transaction of $25,491.50. Following the sale, the executive vice president now owns 36,250 shares of the company’s stock, valued at approximately $5,435,687.50. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, CEO Francois Locoh-Donou sold 2,201 shares of F5 stock in a transaction dated Tuesday, January 3rd. The shares were sold at an average price of $144.21, for a total transaction of $317,406.21. Following the transaction, the chief executive officer now directly owns 111,134 shares of the company’s stock, valued at $16,026,634.14. The disclosure for this sale can be found here. Insiders have sold a total of 25,521 shares of company stock valued at $3,747,727 in the last quarter. Insiders own 0.31% of the company’s stock.
Institutional Inflows and Outflows
Wall Street Analyst Weigh In
FFIV has been the topic of several recent analyst reports. StockNews.com initiated coverage on shares of F5 in a research note on Wednesday, October 12th. They issued a “buy” rating on the stock. Piper Sandler lowered their price objective on shares of F5 from $164.00 to $159.00 in a research report on Tuesday, January 17th. Barclays lowered their price objective on shares of F5 from $205.00 to $180.00 and set an “overweight” rating on the stock in a research report on Wednesday, October 26th. Guggenheim initiated coverage on shares of F5 in a research report on Monday. They set a “neutral” rating on the stock. Finally, JPMorgan Chase & Co. lowered their price objective on shares of F5 from $190.00 to $170.00 and set a “neutral” rating on the stock in a research report on Tuesday, December 20th. Nine investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Hold” and a consensus price target of $175.33.
F5 Company Profile
F5, Inc provides multi-cloud application security and delivery solutions in the United States, Europe, the Middle East, Africa, and the Asia Pacific region. The company's multi-cloud application security and delivery solutions enable its customers to develop, deploy, operate, secure, and govern applications in any architecture, from on-premises to the public cloud.
- Get a free copy of the StockNews.com research report on F5 (FFIV)
- Pliant Therapeutics Gaps 34% Higher: More Upside To Come?
- How Will Early 2023 Layoffs Affect These 5 Biotech Stocks?
- Is the Pain Over for Baudax Bio Investors after a 70% Spike?
- Will Rocket Lab’s First U.S. Launch Send Stock Into Stratosphere?
- 3 Retail Stocks Ringing the Register in 2023
Receive News & Ratings for F5 Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for F5 and related companies with MarketBeat.com's FREE daily email newsletter.